BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 16623785)

  • 1. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
    Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
    Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of tenascin-C and matrix metalloproteinases in vascular abnormalities in murine hypoplastic lungs.
    Chinoy MR; Miller SA
    Biol Neonate; 2006; 90(3):185-96. PubMed ID: 16699260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
    González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ
    Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
    Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development.
    Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
    Histopathology; 2005 Oct; 47(4):410-9. PubMed ID: 16178896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta.
    Riley SC; Webb CJ; Leask R; McCaig FM; Howe DC
    J Reprod Fertil; 2000 Jan; 118(1):19-27. PubMed ID: 10793622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries.
    Riley SC; Gibson AH; Leask R; Mauchline DJ; Pedersen HG; Watson ED
    Reproduction; 2001 Apr; 121(4):553-60. PubMed ID: 11277874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
    Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy.
    Pritchard SC; Nicolson MC; Lloret C; McKay JA; Ross VG; Kerr KM; Murray GI; McLeod HL
    Oncol Rep; 2001; 8(2):421-4. PubMed ID: 11182067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J; Windsor LJ
    J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I; Miyake H; Hara S; Arakawa S; Kamidono S
    J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of metalloproteinases and their tissue inhibitors in gingiva affected by hereditary gingival fibromatosis: analysis of three cases within a family.
    Gonçalves Lda R; Oliveira GA; Borojevic R; Otazu IB; Feres-Filho EJ
    J Periodontal Res; 2009 Dec; 44(6):714-7. PubMed ID: 19453853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
    Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
    Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients.
    Soell M; Elkaim R; Tenenbaum H
    J Dent Res; 2002 Mar; 81(3):174-8. PubMed ID: 11876270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.